AdipoRon Promotes Mitochondrial Ca2+ Overload and Apoptosis in Hepatocellular Carcinoma Cells by Activating the PLC-IP3-IP3R Signaling Pathway
Zongmeng Zhang1,2,#, Cai Chen3,#, Shaorui Rui3, Conghan Li3, Jiong Gu3,*, Liang He3,*
1 College of Traditional Chinese Medicine, Bozhou University, Bozhou, 236800, China
2 The School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, China
3 Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China
* Corresponding Author: Jiong Gu. Email: 
; Liang He. Email: 
# These authors contributed equally to this work
BIOCELL https://doi.org/10.32604/biocell.2025.073085
Received 10 September 2025; Accepted 07 November 2025; Published online 05 December 2025
Abstract
Objective: Hepatocellular carcinoma (HCC) ranks among the most prevalent malignant tumors globally. Metabolically associated fatty liver disease is a significant risk factor for HCC. Adiponectin, a key regulatory protein in glucolipid metabolism, presents potential as an anti-tumor target in HCC cells. The study focused on evaluating the anti-HCC properties of AdipoRon, an agonist of the adiponectin receptor.
Method: Cell viability and proliferation were assessed using the cell counting kit-8 and colony formation assays, respectively. AdipoRon’s effect on HCC cell damage was evaluated via flow cytometry, apoptosis, and (lactate dehydrogenase) LDH assays. Mitochondrial function was evaluated by measuring mitochondrial membrane potential (MMP), ATP levels, and Complex I activity. Additionally, mitochondrial reactive oxygen species (ROS) and calcium (Ca
2+) levels were analyzed using MitoSOX Red and Rhod-2 AM probes, respectively.
Results: Our findings indicated that AdipoRon suppressed the proliferation of HCC cells and triggered apoptosis, with both effects being dose-dependent. Furthermore, AdipoRon caused a decrease in mitochondrial membrane potential, ATP levels, and Complex I activity, alongside the generation of mitochondrial ROS. Notably, AdipoRon disrupted intracellular Ca
2+ homeostasis by causing mitochondrial Ca
2+ overload due to release from the endoplasmic reticulum (ER). Additionally, AdipoRon promoted Ca
2+ release from the ER by activating the PLC-IP3-IP3R pathway. The resulting mitochondrial Ca
2+ overload enhances the anti-HCC effect when combined with chemotherapeutic drugs.
Conclusions: Therefore, our study demonstrates that AdipoRon promotes mitochondrial Ca
2+ overload and apoptosis in HCC cells by activating the PLC-IP3-IP3R signaling pathway. AdipoRon has the potential to become an effective anti-HCC drug.
Keywords
Hepatocellular carcinoma; AdipoRon; mitochondrial Ca
2+ overload; apoptosis
Open Access
Login
Register
Submit a Paper
Propose a Special lssue
Download PDF
Downloads
Citation Tools
